Clinical and Regulatory Affairs

The Clinical and Regulatory Affairs team at TILT Biotherapeutics is responsible for overseeing the development and execution of clinical trial strategies while ensuring compliance with regulatory standards. This team collaborates closely on the design and implementation of cancer immunotherapy studies, manages submissions to health authorities, and coordinates cross-functional efforts to advance the company’s innovative treatments from preclinical to clinical stages. Their expertise ensures that TILT’s therapies meet safety and efficacy standards, facilitating timely and successful regulatory approvals.